Alnylam Pharmaceuticals, Inc. (LON:0HD2)

Altus Power Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-269.7	-278.16	-440.24	-1,131	-852.82	-858.28
Depreciation & Amortization	57.56	56.67	54.05	44.47	89.69	74.44
Loss (Gain) From Sale of Investments	4.06	3.02	16.94	33.31	-55.7	-54.04
Stock-Based Compensation	283.45	272.08	221.68	230.65	165.72	139.87
Other Operating Activities	202.2	152.15	194.46	273.84	174.24	95.76
Change in Accounts Receivable	-94.39	-86.55	-87.94	-45.6	-101.8	-56.24
Change in Inventory	19.78	13.59	18.37	-34.14	-26.42	-35.43
Change in Accounts Payable	-59.78	91.09	80.84	191.77	88.24	143.73
Change in Unearned Revenue	-234.2	-235.45	55.02	-65.91	-50.4	-43.97
Change in Other Net Operating Assets	45.92	3.23	-9.03	-38.51	-72.45	-20.81
Operating Cash Flow	-45.11	-8.31	104.16	-541.27	-641.69	-614.96
Capital Expenditures	-30.27	-34.28	-62.21	-72.06	-76.37	-70.36
Investment in Securities	114.14	-63.25	-269.7	254.61	-192.56	-333.96
Other Investing Activities	-19.32	-19.32	-4.44	-13.19	-4.36	-31.2
Investing Cash Flow	64.55	-116.84	-336.35	169.35	-273.3	-435.52
Long-Term Debt Issued	-	-	-	1,016	500	200
Long-Term Debt Repaid	-	-	-	-880.72	-	-
Net Debt Issued (Repaid)	-	-	-	135.39	500	200
Issuance of Common Stock	326.46	302.95	147.46	259.36	246.27	299.98
Other Financing Activities	-17.13	-8.79	24.67	31	500.85	495
Financing Cash Flow	309.33	294.16	172.13	425.75	1,247	994.98
Foreign Exchange Rate Adjustments	8.76	-15.24	6.39	-7.43	-9.02	4.92
Net Cash Flow	337.53	153.77	-53.67	46.4	323.11	-50.58
Free Cash Flow	-75.39	-42.59	41.95	-613.33	-718.07	-685.32
Free Cash Flow Margin	-3.21%	-1.89%	2.29%	-59.12%	-85.05%	-139.05%
Free Cash Flow Per Share	-0.59	-0.33	0.34	-5.04	-6.06	-5.96
Cash Interest Paid	103.57	67.58	32.12	45.24	24.66	-
Cash Income Tax Paid	15.34	14.36	6.02	2.65	-	-
Levered Free Cash Flow	223.09	197.88	103.55	-444.35	97.11	-777.14
Unlevered Free Cash Flow	313.87	286.54	179.32	-346.87	186.5	-724.33
Change in Net Working Capital	-75.25	-102.62	-142.15	59.25	-450.37	350.5

Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.